These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3038714)

  • 1. [Specific inhibitory action of a novel antidepressant paroxetine on 5-HT uptake].
    Tanigaki N; Manno K; Sugihara K; Miki N; Ichida S; Yoshida H
    Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):175-80. PubMed ID: 3038714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor.
    Thomas DR; Nelson DR; Johnson AM
    Psychopharmacology (Berl); 1987; 93(2):193-200. PubMed ID: 2962217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
    Galzin AM; Moret C; Verzier B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antidepressant drugs on different receptors in the brain.
    Hall H; Ogren SO
    Eur J Pharmacol; 1981 Mar; 70(3):393-407. PubMed ID: 6262100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat.
    Chaput Y; de Montigny C; Blier P
    Neuropsychopharmacology; 1991 Dec; 5(4):219-29. PubMed ID: 1839498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central serotonergic uptake mechanisms in hypertensive rats: effects of clonidine and centhaquin.
    Gulati A; Arora RC; Crayton J
    Eur J Pharmacol; 1993 Feb; 231(2):151-6. PubMed ID: 8453971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the animal pharmacology of paroxetine.
    Johnson AM
    Acta Psychiatr Scand Suppl; 1989; 350():14-20. PubMed ID: 2530769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.
    Mellerup ET; Plenge P; Engelstoft M
    Eur J Pharmacol; 1983 Dec; 96(3-4):303-9. PubMed ID: 6233162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alaproclate, a new selective 5-HT uptake inhibitor with therapeutic potential in depression and senile dementia.
    Ogren SO; Holm AC; Hall H; Lindberg UH
    J Neural Transm; 1984; 59(4):265-88. PubMed ID: 6205120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some effects of chronic antidepressant treatments on rat brain monoaminergic systems.
    Sugrue MF
    J Neural Transm; 1983; 57(4):281-95. PubMed ID: 6197507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the serotonergic system in the mode of action of the new potential antidepressant agent 5-methoxyindolyl-2-methylamine.
    Carranza Gómez-Carpintero MC; Ochoa Estomba MC
    Arzneimittelforschung; 1993 Aug; 43(8):809-13. PubMed ID: 8216432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of [3H]paroxetine binding in rat brain.
    Marcusson JO; Bergström M; Eriksson K; Ross SB
    J Neurochem; 1988 Jun; 50(6):1783-90. PubMed ID: 2967349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-related changes in rat serotonergic and adrenergic systems and in receptor responsiveness to subchronic desipramine treatment.
    Brunello N; Riva M; Rovescalli AC; Galimberti R; Racagni G
    Pharmacol Toxicol; 1988 Sep; 63(3):150-5. PubMed ID: 2460847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
    Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
    J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of McN-5707 as a potential antidepressant.
    Shank RP; Gardocki JF; Schneider CR; Vaught JL; Setler PE; Maryanoff BE; McComsey DF
    J Pharmacol Exp Ther; 1987 Jul; 242(1):74-84. PubMed ID: 3039115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs.
    Blier P; Bouchard C
    Br J Pharmacol; 1994 Oct; 113(2):485-95. PubMed ID: 7834200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.
    Watanabe Y; Sakai RR; McEwen BS; Mendelson S
    Brain Res; 1993 Jun; 615(1):87-94. PubMed ID: 8364729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antidepressive drugs can change the affinity of [3H]imipramine and [3H]paroxetine binding to platelet and neuronal membranes.
    Plenge P; Mellerup ET
    Eur J Pharmacol; 1985 Dec; 119(1-2):1-8. PubMed ID: 2935414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro.
    Hyttel J
    Psychopharmacology (Berl); 1978 Dec; 60(1):13-8. PubMed ID: 104340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.